VivoSeq
Other

Precocious Puberty

17

Pipeline Programs↗

2

Active Trials↗

10

Companies Involved↗

Precocious Puberty is an emerging landscape with 17 programs across 10 companies. The most active players are Novartis, Pfizer, Karuna Therapeutics, Inc., a Bristol Myers Squibb company. 8 therapies are approved with 1 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

44/100

Pipeline Velocity

0/100

Mech. Concentration

30/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novartis logo

Novartis

1 program

Phase 1Pfizer logo

Pfizer

1 program

Phase 2K

Karuna Therapeutics, Inc., a Bristol Myers Squibb company

1 program

Phase 2Ipsen logo

Ipsen

1 program

Phase 3Daewoong Pharmaceutical Co. LTD. logo

Daewoong Pharmaceutical Co. LTD.

1 program

ApprovedF

Fresenius Kabi Oncology Ltd.

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

12

clinical trials

Completed9 · 75%
Recruiting1 · 8%
Unknown status1 · 8%
Not yet recruiting1 · 8%

Clinical Trials

Trial Activity

12 trials

A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty
Recruiting·—·Phase 3·NCT06510764·170 enrolled
Danish Precocious Puberty Study - DAPP Study A National Cohort Study on Incidence and Etiologies for Precocious Puberty
Not yet recruiting·—·N/A·NCT05957991·1,500 enrolled
Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study
Completed·Ipsen logoIpsen·Phase 3·NCT00909844·35 enrolled
Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty
Completed·Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·Phase 2·NCT00001181·100 enrolled
Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty
Completed·Ipsen logoIpsen·Phase 3·NCT00564850·37 enrolled
The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
Completed·Daewoong Pharmaceutical Co. LTD. logoDaewoong Pharmaceutical Co. LTD.·Phase 4·NCT01634321·63 enrolled
Purification of Testis-Stimulating Factor in Precocious Puberty
Completed·NNational Center for Research Resources (NCRR)·N/A·NCT00004344·4 enrolled
Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
Completed·National Institute of Dental and Craniofacial Research (NIDCR)·Phase 1·NCT00006174·25 enrolled
Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty
Completed·—·N/A·NCT02650141·143 enrolled
Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty
Completed·RRuijin Hospital·Phase 4·NCT02920515·740 enrolled
Treatment of Boys With Precocious Puberty
Completed·Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·Phase 2·NCT00001202·80 enrolled
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
Unknown status·UUniversity of Pisa·Phase 4·NCT00438217·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)